Denham refers new round of cancer drugs to NICE
The National Institute for Clinical Excellence is to rule on whether a range of anti-cancer drugs should be available on the NHS. Health minister John Denham has referred a series of treatments to NICE, in a two-year programme. The list covers therapies for lung, colorectal, blood, breast, ovarian, brain and pancreatic cancers. NICE chief executive Andrew Dillon said the institute would contact patient organisations, professional bodies and manufacturers interested in temozolamide for ...
Register now for free to view this page
Please register now to access this content
This content is for registered users only
To check that you are registered please enter your email address below
Not registered?
Registration is simple and quick. By registering you will be able to read selected articles on HSJ.co.uk, PLUS sign up to HSJ email newsletters straight away.
